カテゴリ： GlobalInfoResearch, 世界, 産業機械/建設

世界の吸入抗生物質市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Inhaled Antibiotics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO17011）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO17011
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：産業機器
■ ページ数：91
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の吸入抗生物質市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

吸入抗生物質市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の吸入抗生物質の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

吸入抗生物質市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ネブライザー、ドライパウダー

用途別セグメントは次のように区分されます。
・人工呼吸器関連肺炎（VAP）、人工呼吸器関連気管気管支炎（VAT）、その他

世界の吸入抗生物質市場の主要な市場プレーヤーは以下のとおりです。
・Lupin、Gilead Sciences, Inc、Savara Pharmaceuticals、Aradigm、Polyphor、Pharmaero、Pharmaxis Ltd、Insmed Incorporated、Joincare Pharmaceutical Group

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、吸入抗生物質製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な吸入抗生物質メーカーの企業概要、2019年～2022年までの吸入抗生物質の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な吸入抗生物質メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別吸入抗生物質の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの吸入抗生物質の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での吸入抗生物質市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および吸入抗生物質の産業チェーンを掲載しています。
・第13、14、15章では、吸入抗生物質の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 吸入抗生物質の概要
- 種類別分析（2017年vs2021年vs2028年）：ネブライザー、ドライパウダー
- 用途別分析（2017年vs2021年vs2028年）：人工呼吸器関連肺炎（VAP）、人工呼吸器関連気管気管支炎（VAT）、その他
- 世界の吸入抗生物質市場規模・予測
- 世界の吸入抗生物質生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Lupin、Gilead Sciences, Inc、Savara Pharmaceuticals、Aradigm、Polyphor、Pharmaero、Pharmaxis Ltd、Insmed Incorporated、Joincare Pharmaceutical Group
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ネブライザー、ドライパウダー
・用途別分析2017年-2028年：人工呼吸器関連肺炎（VAP）、人工呼吸器関連気管気管支炎（VAT）、その他
・吸入抗生物質の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・吸入抗生物質のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・吸入抗生物質のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・吸入抗生物質の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・吸入抗生物質の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Inhaled Antibiotics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Inhaled Antibiotics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Ventilator-associated Pneumonia, VAP accounting for % of the Inhaled Antibiotics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Nebulized segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Inhaled Antibiotics include Lupin, Gilead Sciences, Inc, Savara Pharmaceuticals, Aradigm, and Polyphor, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Inhaled Antibiotics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Nebulized
Dry Powder
Market segment by Application can be divided into
Ventilator-associated Pneumonia, VAP
Ventilator-associated Tracheobronchitis, VAT
Others
The key market players for global Inhaled Antibiotics market are listed below:
Lupin
Gilead Sciences, Inc
Savara Pharmaceuticals
Aradigm
Polyphor
Pharmaero
Pharmaxis Ltd
Insmed Incorporated
Joincare Pharmaceutical Group
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Inhaled Antibiotics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Inhaled Antibiotics, with price, sales, revenue and global market share of Inhaled Antibiotics from 2019 to 2022.
Chapter 3, the Inhaled Antibiotics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inhaled Antibiotics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Inhaled Antibiotics market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Inhaled Antibiotics.
Chapter 13, 14, and 15, to describe Inhaled Antibiotics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Inhaled Antibiotics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Inhaled Antibiotics Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Nebulized
1.2.3 Dry Powder
1.3 Market Analysis by Application
1.3.1 Overview: Global Inhaled Antibiotics Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Ventilator-associated Pneumonia, VAP
1.3.3 Ventilator-associated Tracheobronchitis, VAT
1.3.4 Others
1.4 Global Inhaled Antibiotics Market Size & Forecast
1.4.1 Global Inhaled Antibiotics Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Inhaled Antibiotics Sales in Volume (2017-2028)
1.4.3 Global Inhaled Antibiotics Price (2017-2028)
1.5 Global Inhaled Antibiotics Production Capacity Analysis
1.5.1 Global Inhaled Antibiotics Total Production Capacity (2017-2028)
1.5.2 Global Inhaled Antibiotics Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Inhaled Antibiotics Market Drivers
1.6.2 Inhaled Antibiotics Market Restraints
1.6.3 Inhaled Antibiotics Trends Analysis
2 Manufacturers Profiles
2.1 Lupin
2.1.1 Lupin Details
2.1.2 Lupin Major Business
2.1.3 Lupin Inhaled Antibiotics Product and Services
2.1.4 Lupin Inhaled Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Gilead Sciences, Inc
2.2.1 Gilead Sciences, Inc Details
2.2.2 Gilead Sciences, Inc Major Business
2.2.3 Gilead Sciences, Inc Inhaled Antibiotics Product and Services
2.2.4 Gilead Sciences, Inc Inhaled Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Savara Pharmaceuticals
2.3.1 Savara Pharmaceuticals Details
2.3.2 Savara Pharmaceuticals Major Business
2.3.3 Savara Pharmaceuticals Inhaled Antibiotics Product and Services
2.3.4 Savara Pharmaceuticals Inhaled Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Aradigm
2.4.1 Aradigm Details
2.4.2 Aradigm Major Business
2.4.3 Aradigm Inhaled Antibiotics Product and Services
2.4.4 Aradigm Inhaled Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Polyphor
2.5.1 Polyphor Details
2.5.2 Polyphor Major Business
2.5.3 Polyphor Inhaled Antibiotics Product and Services
2.5.4 Polyphor Inhaled Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Pharmaero
2.6.1 Pharmaero Details
2.6.2 Pharmaero Major Business
2.6.3 Pharmaero Inhaled Antibiotics Product and Services
2.6.4 Pharmaero Inhaled Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Pharmaxis Ltd
2.7.1 Pharmaxis Ltd Details
2.7.2 Pharmaxis Ltd Major Business
2.7.3 Pharmaxis Ltd Inhaled Antibiotics Product and Services
2.7.4 Pharmaxis Ltd Inhaled Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Insmed Incorporated
2.8.1 Insmed Incorporated Details
2.8.2 Insmed Incorporated Major Business
2.8.3 Insmed Incorporated Inhaled Antibiotics Product and Services
2.8.4 Insmed Incorporated Inhaled Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Joincare Pharmaceutical Group
2.9.1 Joincare Pharmaceutical Group Details
2.9.2 Joincare Pharmaceutical Group Major Business
2.9.3 Joincare Pharmaceutical Group Inhaled Antibiotics Product and Services
2.9.4 Joincare Pharmaceutical Group Inhaled Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Inhaled Antibiotics Breakdown Data by Manufacturer
3.1 Global Inhaled Antibiotics Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Inhaled Antibiotics Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Inhaled Antibiotics
3.4 Market Concentration Rate
3.4.1 Top 3 Inhaled Antibiotics Manufacturer Market Share in 2021
3.4.2 Top 6 Inhaled Antibiotics Manufacturer Market Share in 2021
3.5 Global Inhaled Antibiotics Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Inhaled Antibiotics Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Inhaled Antibiotics Market Size by Region
4.1.1 Global Inhaled Antibiotics Sales in Volume by Region (2017-2028)
4.1.2 Global Inhaled Antibiotics Revenue by Region (2017-2028)
4.2 North America Inhaled Antibiotics Revenue (2017-2028)
4.3 Europe Inhaled Antibiotics Revenue (2017-2028)
4.4 Asia-Pacific Inhaled Antibiotics Revenue (2017-2028)
4.5 South America Inhaled Antibiotics Revenue (2017-2028)
4.6 Middle East and Africa Inhaled Antibiotics Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Inhaled Antibiotics Sales in Volume by Type (2017-2028)
5.2 Global Inhaled Antibiotics Revenue by Type (2017-2028)
5.3 Global Inhaled Antibiotics Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Inhaled Antibiotics Sales in Volume by Application (2017-2028)
6.2 Global Inhaled Antibiotics Revenue by Application (2017-2028)
6.3 Global Inhaled Antibiotics Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Inhaled Antibiotics Sales by Type (2017-2028)
7.2 North America Inhaled Antibiotics Sales by Application (2017-2028)
7.3 North America Inhaled Antibiotics Market Size by Country
7.3.1 North America Inhaled Antibiotics Sales in Volume by Country (2017-2028)
7.3.2 North America Inhaled Antibiotics Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Inhaled Antibiotics Sales by Type (2017-2028)
8.2 Europe Inhaled Antibiotics Sales by Application (2017-2028)
8.3 Europe Inhaled Antibiotics Market Size by Country
8.3.1 Europe Inhaled Antibiotics Sales in Volume by Country (2017-2028)
8.3.2 Europe Inhaled Antibiotics Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Inhaled Antibiotics Sales by Type (2017-2028)
9.2 Asia-Pacific Inhaled Antibiotics Sales by Application (2017-2028)
9.3 Asia-Pacific Inhaled Antibiotics Market Size by Region
9.3.1 Asia-Pacific Inhaled Antibiotics Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Inhaled Antibiotics Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Inhaled Antibiotics Sales by Type (2017-2028)
10.2 South America Inhaled Antibiotics Sales by Application (2017-2028)
10.3 South America Inhaled Antibiotics Market Size by Country
10.3.1 South America Inhaled Antibiotics Sales in Volume by Country (2017-2028)
10.3.2 South America Inhaled Antibiotics Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Inhaled Antibiotics Sales by Type (2017-2028)
11.2 Middle East & Africa Inhaled Antibiotics Sales by Application (2017-2028)
11.3 Middle East & Africa Inhaled Antibiotics Market Size by Country
11.3.1 Middle East & Africa Inhaled Antibiotics Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Inhaled Antibiotics Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Inhaled Antibiotics and Key Manufacturers
12.2 Manufacturing Costs Percentage of Inhaled Antibiotics
12.3 Inhaled Antibiotics Production Process
12.4 Inhaled Antibiotics Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Inhaled Antibiotics Typical Distributors
13.3 Inhaled Antibiotics Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Inhaled Antibiotics Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Inhaled Antibiotics Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Lupin Basic Information, Manufacturing Base and Competitors
Table 4. Lupin Major Business
Table 5. Lupin Inhaled Antibiotics Product and Services
Table 6. Lupin Inhaled Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Gilead Sciences, Inc Basic Information, Manufacturing Base and Competitors
Table 8. Gilead Sciences, Inc Major Business
Table 9. Gilead Sciences, Inc Inhaled Antibiotics Product and Services
Table 10. Gilead Sciences, Inc Inhaled Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Savara Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Savara Pharmaceuticals Major Business
Table 13. Savara Pharmaceuticals Inhaled Antibiotics Product and Services
Table 14. Savara Pharmaceuticals Inhaled Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Aradigm Basic Information, Manufacturing Base and Competitors
Table 16. Aradigm Major Business
Table 17. Aradigm Inhaled Antibiotics Product and Services
Table 18. Aradigm Inhaled Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Polyphor Basic Information, Manufacturing Base and Competitors
Table 20. Polyphor Major Business
Table 21. Polyphor Inhaled Antibiotics Product and Services
Table 22. Polyphor Inhaled Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Pharmaero Basic Information, Manufacturing Base and Competitors
Table 24. Pharmaero Major Business
Table 25. Pharmaero Inhaled Antibiotics Product and Services
Table 26. Pharmaero Inhaled Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Pharmaxis Ltd Basic Information, Manufacturing Base and Competitors
Table 28. Pharmaxis Ltd Major Business
Table 29. Pharmaxis Ltd Inhaled Antibiotics Product and Services
Table 30. Pharmaxis Ltd Inhaled Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Insmed Incorporated Basic Information, Manufacturing Base and Competitors
Table 32. Insmed Incorporated Major Business
Table 33. Insmed Incorporated Inhaled Antibiotics Product and Services
Table 34. Insmed Incorporated Inhaled Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Joincare Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 36. Joincare Pharmaceutical Group Major Business
Table 37. Joincare Pharmaceutical Group Inhaled Antibiotics Product and Services
Table 38. Joincare Pharmaceutical Group Inhaled Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Inhaled Antibiotics Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Inhaled Antibiotics Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Inhaled Antibiotics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Inhaled Antibiotics Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Inhaled Antibiotics Production Site of Key Manufacturer
Table 44. Inhaled Antibiotics New Entrant and Capacity Expansion Plans
Table 45. Inhaled Antibiotics Mergers & Acquisitions in the Past Five Years
Table 46. Global Inhaled Antibiotics Sales by Region (2017-2022) & (K Units)
Table 47. Global Inhaled Antibiotics Sales by Region (2023-2028) & (K Units)
Table 48. Global Inhaled Antibiotics Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Inhaled Antibiotics Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Inhaled Antibiotics Sales by Type (2017-2022) & (K Units)
Table 51. Global Inhaled Antibiotics Sales by Type (2023-2028) & (K Units)
Table 52. Global Inhaled Antibiotics Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Inhaled Antibiotics Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Inhaled Antibiotics Price by Type (2017-2022) & (US$/Unit)
Table 55. Global Inhaled Antibiotics Price by Type (2023-2028) & (US$/Unit)
Table 56. Global Inhaled Antibiotics Sales by Application (2017-2022) & (K Units)
Table 57. Global Inhaled Antibiotics Sales by Application (2023-2028) & (K Units)
Table 58. Global Inhaled Antibiotics Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Inhaled Antibiotics Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Inhaled Antibiotics Price by Application (2017-2022) & (US$/Unit)
Table 61. Global Inhaled Antibiotics Price by Application (2023-2028) & (US$/Unit)
Table 62. North America Inhaled Antibiotics Sales by Country (2017-2022) & (K Units)
Table 63. North America Inhaled Antibiotics Sales by Country (2023-2028) & (K Units)
Table 64. North America Inhaled Antibiotics Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Inhaled Antibiotics Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Inhaled Antibiotics Sales by Type (2017-2022) & (K Units)
Table 67. North America Inhaled Antibiotics Sales by Type (2023-2028) & (K Units)
Table 68. North America Inhaled Antibiotics Sales by Application (2017-2022) & (K Units)
Table 69. North America Inhaled Antibiotics Sales by Application (2023-2028) & (K Units)
Table 70. Europe Inhaled Antibiotics Sales by Country (2017-2022) & (K Units)
Table 71. Europe Inhaled Antibiotics Sales by Country (2023-2028) & (K Units)
Table 72. Europe Inhaled Antibiotics Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Inhaled Antibiotics Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Inhaled Antibiotics Sales by Type (2017-2022) & (K Units)
Table 75. Europe Inhaled Antibiotics Sales by Type (2023-2028) & (K Units)
Table 76. Europe Inhaled Antibiotics Sales by Application (2017-2022) & (K Units)
Table 77. Europe Inhaled Antibiotics Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Inhaled Antibiotics Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Inhaled Antibiotics Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Inhaled Antibiotics Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Inhaled Antibiotics Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Inhaled Antibiotics Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Inhaled Antibiotics Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Inhaled Antibiotics Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Inhaled Antibiotics Sales by Application (2023-2028) & (K Units)
Table 86. South America Inhaled Antibiotics Sales by Country (2017-2022) & (K Units)
Table 87. South America Inhaled Antibiotics Sales by Country (2023-2028) & (K Units)
Table 88. South America Inhaled Antibiotics Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Inhaled Antibiotics Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Inhaled Antibiotics Sales by Type (2017-2022) & (K Units)
Table 91. South America Inhaled Antibiotics Sales by Type (2023-2028) & (K Units)
Table 92. South America Inhaled Antibiotics Sales by Application (2017-2022) & (K Units)
Table 93. South America Inhaled Antibiotics Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Inhaled Antibiotics Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Inhaled Antibiotics Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Inhaled Antibiotics Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Inhaled Antibiotics Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Inhaled Antibiotics Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Inhaled Antibiotics Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Inhaled Antibiotics Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Inhaled Antibiotics Sales by Application (2023-2028) & (K Units)
Table 102. Inhaled Antibiotics Raw Material
Table 103. Key Manufacturers of Inhaled Antibiotics Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Inhaled Antibiotics Typical Distributors
Table 107. Inhaled Antibiotics Typical Customers
List of Figures
Figure 1. Inhaled Antibiotics Picture
Figure 2. Global Inhaled Antibiotics Revenue Market Share by Type in 2021
Figure 3. Nebulized
Figure 4. Dry Powder
Figure 5. Global Inhaled Antibiotics Revenue Market Share by Application in 2021
Figure 6. Ventilator-associated Pneumonia, VAP
Figure 7. Ventilator-associated Tracheobronchitis, VAT
Figure 8. Others
Figure 9. Global Inhaled Antibiotics Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Inhaled Antibiotics Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Inhaled Antibiotics Sales (2017-2028) & (K Units)
Figure 12. Global Inhaled Antibiotics Price (2017-2028) & (US$/Unit)
Figure 13. Global Inhaled Antibiotics Production Capacity (2017-2028) & (K Units)
Figure 14. Global Inhaled Antibiotics Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Inhaled Antibiotics Market Drivers
Figure 16. Inhaled Antibiotics Market Restraints
Figure 17. Inhaled Antibiotics Market Trends
Figure 18. Global Inhaled Antibiotics Sales Market Share by Manufacturer in 2021
Figure 19. Global Inhaled Antibiotics Revenue Market Share by Manufacturer in 2021
Figure 20. Inhaled Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Inhaled Antibiotics Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Inhaled Antibiotics Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Inhaled Antibiotics Sales Market Share by Region (2017-2028)
Figure 24. Global Inhaled Antibiotics Revenue Market Share by Region (2017-2028)
Figure 25. North America Inhaled Antibiotics Revenue (2017-2028) & (USD Million)
Figure 26. Europe Inhaled Antibiotics Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Inhaled Antibiotics Revenue (2017-2028) & (USD Million)
Figure 28. South America Inhaled Antibiotics Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Inhaled Antibiotics Revenue (2017-2028) & (USD Million)
Figure 30. Global Inhaled Antibiotics Sales Market Share by Type (2017-2028)
Figure 31. Global Inhaled Antibiotics Revenue Market Share by Type (2017-2028)
Figure 32. Global Inhaled Antibiotics Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Inhaled Antibiotics Sales Market Share by Application (2017-2028)
Figure 34. Global Inhaled Antibiotics Revenue Market Share by Application (2017-2028)
Figure 35. Global Inhaled Antibiotics Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Inhaled Antibiotics Sales Market Share by Type (2017-2028)
Figure 37. North America Inhaled Antibiotics Sales Market Share by Application (2017-2028)
Figure 38. North America Inhaled Antibiotics Sales Market Share by Country (2017-2028)
Figure 39. North America Inhaled Antibiotics Revenue Market Share by Country (2017-2028)
Figure 40. United States Inhaled Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Inhaled Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Inhaled Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Inhaled Antibiotics Sales Market Share by Type (2017-2028)
Figure 44. Europe Inhaled Antibiotics Sales Market Share by Application (2017-2028)
Figure 45. Europe Inhaled Antibiotics Sales Market Share by Country (2017-2028)
Figure 46. Europe Inhaled Antibiotics Revenue Market Share by Country (2017-2028)
Figure 47. Germany Inhaled Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Inhaled Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Inhaled Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Inhaled Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Inhaled Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Inhaled Antibiotics Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Inhaled Antibiotics Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Inhaled Antibiotics Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Inhaled Antibiotics Revenue Market Share by Region (2017-2028)
Figure 56. China Inhaled Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Inhaled Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Inhaled Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Inhaled Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Inhaled Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Inhaled Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Inhaled Antibiotics Sales Market Share by Type (2017-2028)
Figure 63. South America Inhaled Antibiotics Sales Market Share by Application (2017-2028)
Figure 64. South America Inhaled Antibiotics Sales Market Share by Country (2017-2028)
Figure 65. South America Inhaled Antibiotics Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Inhaled Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Inhaled Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Inhaled Antibiotics Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Inhaled Antibiotics Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Inhaled Antibiotics Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Inhaled Antibiotics Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Inhaled Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Inhaled Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Inhaled Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Inhaled Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Inhaled Antibiotics in 2021
Figure 77. Manufacturing Process Analysis of Inhaled Antibiotics
Figure 78. Inhaled Antibiotics Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の医療用吸入式一NO（一酸化窒素）市場2022年：市場規模予測（～2028年）
  • 吸入一酸化窒素マシンの世界市場2023年：携帯型一酸化窒素機、据置型一酸化窒素機
  • 世界の経口用抗生物質市場2022年：市場規模予測（～2028年）
  • 世界のカルバペネム系抗生物質市場2022年：市場規模予測（～2028年）
  • 世界のエルシニア症治療用抗生物質市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO17011 )"世界の吸入抗生物質市場2022年：市場規模予測（～2028年）" (英文：Global Inhaled Antibiotics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。